Home » U.S., Poland Agree to Exchange GMP Inspection Results
U.S., Poland Agree to Exchange GMP Inspection Results
November 11, 2013
The U.S. Food and Drug Administration and Poland’s Główny Inspektorat Farmaceutyczny have agreed to share the results of good manufacturing practice inspections, building on a practice increasingly embraced by regulators around the world.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor